Search

Search Constraints

You searched for: Author/Creator Muls, Vinciane

Search Results

1. Changes of Laryngeal and Extralaryngeal Symptoms and Findings in Laryngopharyngeal Reflux Patients. (5th August 2020)

2. Development and Validation of the Short Version of the Reflux Symptom Score: Reflux Symptom Score–12. (21st July 2020)

3. Development and Validation of the Short Version of the Reflux Symptom Score: Reflux Symptom Score–12. (January 2021)

4. Does Pepsin Saliva Concentration (Peptest™) Predict the Therapeutic Response of Laryngopharyngeal Reflux Patients?. (September 2021)

5. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

6. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022)

7. Gastroesophageal reflux in laryngopharyngeal reflux patients: Clinical features and therapeutic response. (26th December 2019)

8. Hypopharyngeal‐Esophageal Impedance‐pH Monitoring Profiles of Laryngopharyngeal Reflux Patients. (21st May 2020)

10. Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus—A Multicenter Retrospective Study. Issue 9 (5th June 2017)